Correlation between HLA-DRB1, HLA-DQB1 Polymorphism and Autoantibodies Against Angiotensin AT1 Receptors in Chinese Patients with Essential Hypertension

Clinical Cardiology

Volumn 34, Issue 5, 2011, Pages 302-308

  Zhu, Feng ^a   Sun, Yanxiang ^a   Wang, Min ^a   Ma, Shihui ^b   Chen, Xiao ^a   Cao, Ailin ^a   Chen, Fen ^a   Qiu, Yan ^a   Liao, Yuhua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN AT1 RECEPTOR ANTIBODY; AUTOANTIBODY; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANTIBODY PRODUCTION; ARTICLE; BLOOD PRESSURE; CORRELATION ANALYSIS; DNA FINGERPRINTING; ESSENTIAL HYPERTENSION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 79955908602     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20852     Document Type: Article

References (40)

1. Liao YH, Wei YM, Wang M, et al. Autoantibodies against AT1-receptor and alpha1-adrenergic receptors in patients with hypertension. Hypertens Res. 2002; 25: 641-646.
2. Fu ML, Leung PS, Wallukat G, et al. Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press. 1999; 8: 317-324. (Pubitemid 30220296)
3. Fu ML, Herlitz H, Schulze W, et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens. 2000; 18: 945-953. (Pubitemid 30459497)
4. Dechend R, Homuth V, Wallukat G, et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000; 101: 2382-2387. (Pubitemid 30329128)
5. Thway TM, Shlykov SG, Day MC, et al. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation [published correction appears in Circulation. 2004;110:3156]. Circulation. 2004; 110: 1612-1619. (Pubitemid 39297984)
6. Dechend R, Homuth V, Wallukat G, et al. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Investig. 2006; 13: 79-86. (Pubitemid 43155838)
7. Dragun D, Müller DN, Bräsen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005; 352: 558-569. (Pubitemid 40204669)
8. Okruhlicova L, Morwinski R, Schulze W, et al. Autoantibodies against G-protein-coupled receptors modulate heart mast cells. Cell Mol Immunol. 2007; 4: 127-133.
9. Fu ML., Do immune system changes have a role in hypertension? J Hypertens. 1995; 13: 1259-1265. (Pubitemid 26003263)
10. Price P, Witt C, Allcock R, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 1999; 167: 257-274. (Pubitemid 29178987)
11. Ogata T, Gregoire L, Goddard KA, et al. Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study. BMC Med Genet. 2006; 7: 67.
12. Warrens AN, Lechler RI, eds. HLA in Health and Disease. London, England: Academic Press; 2000.
13. Van Eden W., Immunoregulation of autoimmune diseases. Hum Immunol. 2006; 67: 446-453.
14. Trowsdale J, Powis SH., The MHC: relationship between linkage and function. Curr Opin Genet Dev. 1992; 2: 492-497.
15. Janeway CA Jr, Travers P, Walport M, et al. The recognition of antigen. In: Immunobiology: The Immune System in Health and Disease. 6th ed. New York, NY: Taylor & Francis Group/Garland Science; 2005: 103-130.
16. O'Hanlon TP, Rider LG, Mamyrova G, et al. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 2006; 54: 3670-3681. (Pubitemid 44737180)
17. Liu W, Li WM, Sun NL., HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China. Ann Hum Genet. 2005; 69 (part 4): 382-388. (Pubitemid 40990561)
18. Fanning GC, Welsh KI, Bunn C, et al. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol. 1998; 37: 201-207.
19. Gerbase-DeLima M, Ladalardo MA, DeLima JJ, et al. Essential hypertension and histocompatibility antigens: an association study. Hypertension. 1992; 19: 400-402.
20. Titkov YS, Ziskina RA, Temirov AA, et al. HLA antigens in borderline and essential hypertension. Am J Hypertens. 1993; 6: 885-887. (Pubitemid 23329589)
21. Gerbase-DeLima M, Paiva RLF, Bortolotto LA, et al. Human leukocyte antigens and malignant essential hypertension. Am J Hypertens. 1998; 11 (6 part 1): 729-731. (Pubitemid 28313693)
22. Fields HA, Davis CL, Bradley DW, et al. Experimental conditions affecting the sensitivity of enzyme-linked immunosorbent assay (ELISA) for detection of hepatitis B surface antigen (HBsAg). Bull World Health Organ. 1983; 61: 135-142. (Pubitemid 13146880)
23. Zhou Z, Liao YH, Wei Y, et al. Cardiac remodeling after long-term stimulation by antibodies against the alpha1-adrenergic receptor in rats. Clin Immunol. 2005; 114: 164-173. (Pubitemid 40082382)
24. Olerup O, Zetterquist H., HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992; 39: 225-235.
25. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995; 46: 355-367. (Pubitemid 26001354)
26. Olerup O, Aldener A, Fogdell A., HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens. 1993; 41: 119-134. (Pubitemid 23139836)
27. Shi YY, He L., SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005; 15: 97-98. (Pubitemid 41653949)
28. Oldstone MB., Molecular mimicry and immune-mediated diseases. FASEB J. 1998; 12: 1255-1265. (Pubitemid 28475568)
29. Hilme E, Hansson L, Sandberg L, et al. Abnormal immune function in malignant hypertension. J Hypertens. 1993; 11: 989-994. (Pubitemid 23277475)
30. Lefkos N, Boura P, Boudonas G, et al. Immunopathogenic mechanisms in hypertension. Am J Hypertens. 1995; 8: 1141-1145.
31. Fugger L, Rothbard JB, Sonderstrup-McDevitt G., Specificity of an HLADRB1*0401-restricted T cell response to type II collagen. Eur J Immunol. 1996; 26: 928-933.
32. Lin L, Chen Y, Xiao Z, et al. The association of HLA-DRB1 alleles with rheumatoid arthritis in the Chinese Shantou population: a follow-up study. Biochem Cell Biol. 2007; 85: 227-238. (Pubitemid 46841692)
33. Kilpatrick DC, Liston WA, Gibson F, et al. Association between susceptibility to pre-eclampsia within families and HLA DR4. Lancet. 1989; 2: 1063-1065. (Pubitemid 19264074)
34. Limas C, Limas CJ, Boudoulas H, et al. Anti-beta-receptor antibodies in familial cardiomyopathy: correlation with HLA-DR and HLA-DQ gene polymorphisms. Am Heart J. 1994; 127: 382-386. (Pubitemid 24063231)
35. Takakuwa K, Honda K, Ishii K, et al. Studies on the HLA-DRB1 genotypes in Japanese women with severe preeclampsia positive and negative for cardiolipin antibody using a polymerase chain reaction-restriction fragment length polymorphism method. Hum Reprod. 1999; 14: 2980-2986.
36. Limas CJ, Limas C., HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy. Br Heart J. 1992; 67: 402-405.
37. Ou D, Mitchell LA, Tingle AJ., HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. J Rheumatol. 1997; 24: 253-261. (Pubitemid 27104086)
38. Weyand CM, Goronzy JJ., Association of MHC and rheumatoid arthritis: HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res. 2000; 2: 212-216. (Pubitemid 32223730)
39. Schork NJ., Genetically complex cardiovascular traits: origins, problems, and potential solutions. Hypertension. 1997; 29: 145-149. (Pubitemid 27074035)
40. Rioux JD, Abbas AK., Paths to understanding the genetic basis of autoimmune disease. Nature. 2005; 435: 584-589. (Pubitemid 40825497)